Table 2 Patients’ characteristics and levels of CMTM1_v17 expression pre- and post-NAC (n = 31)
Variable | Pre-NAC | Post-NAC | ||||
|---|---|---|---|---|---|---|
CMTM1_v17 expression no. (%) | P value | CMTM1_v17 expression no. (%) | P value | |||
High | Low | High | Low | |||
Age | Â | Â | 0.200 | Â | Â | 0.552 |
  ≤ 55 | 7(43.8) | 9(56.3) |  | 7(43.8) | 9(56.2) |  |
  > 55 | 10(66.7) | 5(33.3) |  | 5(33.3) | 10(66.7) |  |
Gender | Â | Â | 0.763 | Â | Â | 0.791 |
 Male | 10(40.0) | 15(60.0) |  | 14(56.0) | 11(44.0) |  |
 Female | 2(33.3) | 4(66.7) |  | 3(50.0) | 3(50.0) |  |
Smoking history | Â | Â | 0.935 | Â | Â | 0.75 |
 Non-smoker | 3(37.5) | 5(62.5) |  | 4(50.0) | 4(50.0) |  |
 Smoker | 9(39.1) | 14(60.9) |  | 13(56.5) | 10(43.5) |  |
Histology | Â | Â | 0.332 | Â | Â | 0.981 |
 Adenocarcinoma | 3(27.3) | 8(72.7) |  | 6(54.5) | 5(45.5) |  |
 Non-adenocarcinoma | 9(45.0) | 11(55.0) |  | 11(55.0) | 9(45.0) |  |
Histologic grading | Â | Â | 0.379 | Â | Â | 0.576 |
 Poorly | 5(31.3) | 11(68.7) |  | 8(50.0) | 8(50.0) |  |
 Moderate and well | 7(46.7) | 8(53.3) |  | 9(60.0) | 6(40.0) |  |
Venous invasion | Â | Â | 0.355 | Â | Â | 0.75 |
 Negative | 10(43.5) | 13(56.5) |  | 13(56.5) | 10(43.5) |  |
 Positive | 2(25.0) | 6(75.0) |  | 4(50.0) | 4(50.0) |  |
Pathological stage | Â | Â | 0.756 | Â | Â | 0.092 |
 I/II | 7(41.2) | 10(58.8) |  | 7(41.2) | 10(58.8) |  |
 III | 5(35.7) | 9(64.3) |  | 10(71.4) | 4(28.6) |  |